APO-NAPROXEN
APOTEX INC
Quick answers
Is there a shortage of APO-NAPROXEN in Canada?
No. There is no current shortage of APO-NAPROXEN 375MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
APO-NAPROXEN
APOTEX INC
PEDIAPHARM NAPROXEN SUSPENSION
MEDEXUS PHARMACEUTICALS INC.
NAPROXEN-NA DF
PRO DOC LIMITEE
NAPROXEN-NA
PRO DOC LIMITEE
ANAPROX DS
SEARCHLIGHT PHARMA INC
TEVA-NAPROXEN EC
TEVA CANADA LIMITED
DIN
00600806
Strength
375MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554178
2MG · DIN 02554194